Kahl, D. J., Hutchings, K. M., Lisabeth, E. M., Haak, A. J., Leipprandt, J. R., Dexheimer, T., . . . Larsen, S. D. (2019). 5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Reponse Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for Scleroderma. J Med Chem.
استشهاد بنمط شيكاغوKahl, Dylan J., et al. "5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Reponse Factor (SRF)-Mediated Gene Transcription As Potential Antifibrotic Agents for Scleroderma." J Med Chem 2019.
MLA استشهادKahl, Dylan J., et al. "5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Reponse Factor (SRF)-Mediated Gene Transcription As Potential Antifibrotic Agents for Scleroderma." J Med Chem 2019.